4//SEC Filing
Virsik Peter 4
Accession 0001209191-24-001815
CIK 0001633932other
Filed
Jan 16, 7:00 PM ET
Accepted
Jan 17, 8:57 PM ET
Size
9.0 KB
Accession
0001209191-24-001815
Insider Transaction Report
Form 4
ESSA Pharma Inc.EPIX
Virsik Peter
Chief Operating Officer
Transactions
- Sale
Common Shares
2024-01-16$10.01/sh−1,718$17,197→ 14,022 total - Exercise/Conversion
Common Shares
2024-01-16$3.23/sh+1,718$5,549→ 15,740 total - Exercise/Conversion
Options
2024-01-16−1,718→ 968,282 totalExercise: $3.23From: 2023-11-07Exp: 2029-10-07→ Common Shares (1,718 underlying)
Footnotes (2)
- [F1]Reflects a transaction effected pursuant to Mr. Virsik's 10b5-1 trading plan. The Rule 10b5-1 trading plan was entered into on August 31, 2023.
- [F2]The price reported in Column 4 is a weighted average price. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price.
Documents
Issuer
ESSA Pharma Inc.
CIK 0001633932
Entity typeother
Related Parties
1- filerCIK 0001826322
Filing Metadata
- Form type
- 4
- Filed
- Jan 16, 7:00 PM ET
- Accepted
- Jan 17, 8:57 PM ET
- Size
- 9.0 KB